Author

Christos Tzitzilonis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abby Marquez· 1 shared Adrian L. Gill· 1 shared Carlos Stahlhut· 1 shared Christopher J. Schulze· 1 shared Daphne Hsieh· 1 shared David Wildes· 1 shared Elena S. Koltun· 1 shared Franziska Haderk· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abby Marquez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 loss

Robert J. Nichols, Franziska Haderk, Carlos Stahlhut, Christopher J. Schulze, Golzar Hemmati, David Wildes, Christos Tzitzilonis, Kasia Mordec, Abby Marquez, Jason Romero, Daphne Hsieh, Gert Kiss, Elena S. Koltun, Adrian L. Gill, Mallika Singh, , Trever G. Bivona

This study shows that inhibiting SHP2 phosphatase effectively targets cancers driven by nucleotide-cycling RAS, RAS-GTP dependent BRAF, or NF1 loss by disrupting RAS-RAF-MEK-ERK signaling.

bioRxiv · Sep 14, 2017 · PreprintCancer Biology